Rephonic
Artwork for BackTable Tumor Board

BackTable Tumor Board

BackTable Inc.
Non-Muscle Invasive Bladder Cancer
Lung Cancer
Bladder Cancer
Hepatocellular Carcinoma
Immunotherapy
Ctdna
Her2-Positive Breast Cancer
Pembrolizumab
Intravascular Therapy
Prostate Cancer
Gemcitabine
BCG Therapy
Testicular Germ Cell Tumors
Pulse Electrical Field Abalation
EBUS
Antibody Drug Conjugates
Pancreatic Cancer
Replimune
Radiopharmaceutical Therapy
Inflammatory Breast Cancer

BackTable Tumor Board is a multi-disciplinary podcast for healthcare professionals that play an active role in cancer care.

PublishesWeeklyEpisodes61Foundeda year ago
Number of ListenersCategories
EducationMedicineHealth & Fitness

Listen to this Podcast

Artwork for BackTable Tumor Board

Latest Episodes

Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect management. In this episode of BackTable Urology, Dr. Neeraj Agarwal and Dr. Arun Azad join host Dr. Alan Tan to discuss practical, evidence... more

YouTube

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and ... more

YouTube

When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options are available for second-line therapy? In this episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhar... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

Recent Guests

Arun Azad
GU Medical Oncologist at the Peter MacCallum Cancer Center
Peter MacCallum Cancer Center
Episode: Ep. 60 PARP Inhibitors: Clinical Trials & Real-World Applications with Dr. Neeraj Agarwal and Dr. Arun Azad
A Craig Lockhart
A Craig Lockhart, MD (assumed)
Charleston-based clinical practice (institution not explicitly stated)
Episode: Ep. 59 Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon? with Dr. A Craig Lockhart and Dr. Lingling Du
Dr. A. Craig Lockhart
Senior oncologist discussing hepatocellular carcinoma therapeutic strategies
Episode: Ep. 58 Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options with Dr. A. Craig Lockhart and Dr. Lingling Du
Dr. Lingling Du
Oncology physician with focus on liver cancer therapies
Episode: Ep. 58 Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options with Dr. A. Craig Lockhart and Dr. Lingling Du
Craig Lockhart
Medical oncologist with extensive experience in GI cancers
Medical University of South Carolina (Charleston)
Episode: Ep. 57 First-Line Therapy for Advanced Hepatocellular Carcinoma: Decisions in the Real World with Dr. A. Craig Lockhart and Dr. Lingling Du
Lingling Du
GI medical oncologist
Osher MD Anderson Cancer Center, New Orleans
Episode: Ep. 57 First-Line Therapy for Advanced Hepatocellular Carcinoma: Decisions in the Real World with Dr. A. Craig Lockhart and Dr. Lingling Du
Jessica Trevino Jones
Associate Professor, Division of Hematology-Oncology; Director of Cancer Genetics and Prevention Program, UT Health San Antonio
UT Health Science Center San Antonio / Mays Cancer Center
Episode: Ep. 56 Breast Cancer Precision Medicine: Biomarkers & Treatments with Dr. Jessica Treviño Jones
Marcia Ciccone
Attending GYN oncologist at the University of Southern California
USC
Episode: Ep. 53 Hereditary GYN Cancer Syndromes: Practical Screening & Risk Reduction Guide with Dr. Marcia Ciccone
Dr. Sara Nunnery
Breast medical oncologist, director of Breast Cancer Research Program
Tennessee Oncology
Episode: Ep. 52 Antibody Drug Conjugates Across the HER2 Spectrum: From HER2-Positive to Ultralow Breast Cancer with Dr. Sara Nunnery

Hosts

Jun Gong
GI Medical Oncologist at Cedars-Sinai Medical Center; guest contributor across multiple episodes.
Jon Mizrahi
Host of BackTable Tumor Board; affiliated with MD Anderson / Ochsner.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

S02 Ep. 16 Insights on Management of Upper Tract Urothelial Cancer with Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Q: Is there a role for a medical oncologist to be involved in this patient's care, given no radiographic metastasis?
A medical oncologist should be involved early to assess eligibility for perioperative platinum-based chemotherapy, which can downstage disease in some cases, and to discuss adjuvant or neoadjuvant options and risks given renal function and comorbidities.
S02 Ep. 16 Insights on Management of Upper Tract Urothelial Cancer with Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Q: With this information, how would you counsel this gentleman on his options?
Dr. Schmidt would consider nephron-sparing and local endoscopic options first given the low-grade nature and preserved renal function, while discussing the risks and close surveillance; for more aggressive disease or limited kidneys, a laser ablation approach or possible percutaneous strategies could be considered, but the overall plan favors preserving renal function with careful monitoring.
S02 Ep. 17 Penile Cancer Management: Insights and Case Studies with Dr. Juanita Crook and Dr. Andrea Apolo
Q: Can you explain the difference between low-dose rate brachytherapy and high-dose rate brachytherapy in penile cancer, and how does that affect patient treatment courses?
Low-dose rate brachytherapy involves delivering a continuous, larger total dose over several days, often requiring longer hospital stays and a steadier exposure, whereas high-dose rate brachytherapy uses shorter, more intense doses over a few days, enabling greater treatment flexibility and often shorter overall duration, with comparable radiobiology when fractionation is optimized.
S02 Ep. 18 Intermediate Risk NMIBC: Patient-Centered Treatment Strategies with Dr. Kelly Bree
Q: What is your preferred initial treatment for intermediate-risk patients with low-grade disease?
Gemcitabine is usually the first-line intravascular option, with BCG reserved for refractory disease; trial enrollment is also encouraged when appropriate.
S02 Ep. 18 Intermediate Risk NMIBC: Patient-Centered Treatment Strategies with Dr. Kelly Bree
Q: How do you determine which patients fall into the intermediate risk category given guideline differences?
Guidelines differ, but common practice considers multifocal, recurrent, large, or low-grade tumors as factors; many clinicians treat any high-grade component as high-risk and reserve aggressive strategies for those cases.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BackTable Tumor Board

What is BackTable Tumor Board about and what kind of topics does it cover?

A multidisciplinary medical podcast that centers on oncology care, surgical oncology, radiology, interventional radiology, and related translational science. Episodes consistently explore cutting-edge cancer therapies, biomarker-driven decision making, perioperative strategies, imaging-guided treatments, and emerging trial data across GU, breast, thoracic, GI, and pancreatic cancers. The show often features clinicians from leading cancer centers discussing trial results, real-world implementation, and the practicalities of integrating novel therapies into multidisciplinary care. A notable strength is its breadth of expert guests—from medical and surgical oncologists to interventional radiologists and imaging specialists—paired with a focus ... more

Where can I find podcast stats for BackTable Tumor Board?

Rephonic provides a wide range of podcast stats for BackTable Tumor Board. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BackTable Tumor Board and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BackTable Tumor Board get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BackTable Tumor Board, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BackTable Tumor Board?

Rephonic provides comprehensive predictive audience data for BackTable Tumor Board, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BackTable Tumor Board have?

To see how many followers or subscribers BackTable Tumor Board has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BackTable Tumor Board?

These podcasts share a similar audience with BackTable Tumor Board:

1. BackTable Vascular & Interventional
2. BackTable Urology
3. The Bill Simmons Podcast
4. Oncology Brothers: Practice-Changing Cancer Discussions
5. The Uromigos

How many episodes of BackTable Tumor Board are there?

BackTable Tumor Board launched a year ago and published 61 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BackTable Tumor Board?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BackTable Tumor Board?

Rephonic pulls ratings and reviews for BackTable Tumor Board from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BackTable Tumor Board?

Rephonic provides full transcripts for episodes of BackTable Tumor Board. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BackTable Tumor Board?

Recent guests on BackTable Tumor Board include:

1. Arun Azad
2. A Craig Lockhart
3. Dr. A. Craig Lockhart
4. Dr. Lingling Du
5. Craig Lockhart
6. Lingling Du
7. Jessica Trevino Jones
8. Marcia Ciccone

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days